Skip to content

AAPM&R Annual Assembly 2026

The AAPM&R Annual Assembly 2026 takes place November 11–14 at the Orange County Convention Center in Orlando, with virtual participation also available. The current agenda includes several ticketed skills labs directly relevant to botulinum toxin injection, spasticity, headache management, ultrasound guidance, and chemodenervation.

FieldCurrent information
DatesNovember 11–14, 2026
VenueOrange County Convention Center, West Concourse, Orlando, Florida
FormatIn person and virtual
Program statusInteractive agenda available
Registration statusOpen
Main toxin contextTherapeutic rehabilitation, spasticity, headache, ultrasound guidance, and chemodenervation
Last checkedJuly 29, 2026

AAPM&R is a broad physical medicine and rehabilitation meeting rather than a dedicated neurotoxin congress. Its toxin relevance is concentrated in practical therapeutic settings, especially spasticity management, cranio-cervical injection, headache care, and image-guided procedures.

The organizer’s current registration agenda identifies the following directly relevant ticketed skills labs. Times and titles may change, so the interactive agenda should control final planning.

Date and timeSessionParticipant context
November 12, 2:00–5:00 pmInterventional Headache Management for the Physiatrist: Peripheral Nerve Blocks, OnabotulinumtoxinA, and Cryotherapy for Headache ManagementIn-person Skills Lab 1804; explicitly includes onabotulinumtoxinA
November 13, 9:00 am–12:00 pmThe Art of Treating Spasticity: Ultrasound WorkshopIn-person Skills Lab 1805; broader spasticity and ultrasound context
November 13, 1:30–4:30 pmUltrasound Guidance for Botulinum Toxin Injections in the Cranio-cervical RegionIn-person Skills Lab 1808; explicitly focused on botulinum toxin guidance
November 14, 9:00 am–12:00 pmUltrasound Guidance for Lower Limb Chemodenervation ProceduresIn-person Skills Lab 1809; broader chemodenervation context without a product named in the official title

The registration page states that ticketed three-hour Skills Labs are not included in the general Annual Assembly registration fee. AAPM&R also lists an in-person STEP 2 — Interventional Spasticity Management Applications preconference course; participants should confirm its schedule and separate registration requirements on the official site.

DateActionStatus
June 24, 2026Late-breaking original research abstract deadlineClosed
October 13, 2026Mail and fax registration cutoffUpcoming
October 13, 2026Official housing deadline for conference rates and availabilityUpcoming
October 13, 2026Cancellation deadline under the organizer’s stated refund policyUpcoming
November 14, 2026Final day for online or on-site registrationUpcoming

The official registration page 🔗 states that online or on-site registration remains available after the mail and fax cutoff, subject to organizer availability. Registration categories, fees, ticketed add-ons, cancellation terms, and room availability should be checked directly before purchase.

In-person and virtual registration include recorded educational sessions for one year. The AAPM&R CME guidance 🔗 states that the meeting can provide up to 117 AMA PRA Category 1 Credits™; separately ticketed Skills Labs and preconference sessions are not included in the on-demand AA Rewind 2026 library.

AAPM&R has opened exhibitor and sponsorship information and published exhibit-hall hours 🔗, but a current public company-by-company directory was not available in the official sources reviewed on July 29, 2026. The exhibit hall is scheduled for November 12 from 12:30–6:30 pm, November 13 from 8:00 am–3:00 pm, and November 14 from 7:45 am–1:30 pm, all in Eastern Time. Company participation should not be inferred from prior editions, sponsorship prospectuses, or promotional photographs.

When an official directory or sponsored-session schedule becomes available, company records can distinguish exhibitors, event sponsors, education-theater sponsors, satellite-symposium hosts, and speaker affiliations rather than combining them into a single participant list.

Program listings establish what the organizer has scheduled; they do not establish product equivalence, approved use, comparative efficacy, or clinical superiority. Product-level interpretation still depends on current labeling and appropriate clinical evidence.